BT-474 cell

SKU:BHC11100222
Bulk Pricing
Overview
Click light‑blue chips for details

BT-474 cell is a cell line derived from Caucasian (Female). It is commonly used as an in vitro model for 1 research. Growth characteristics: The cells grow in compact, slowly growing multi-layered colonies which rarely become confluent. A confluent monolayer is not formed., Epithelial-like. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Invasive ductal carcinoma
Morphology Epithelial-like
Growth Properties The cells grow in compact, slowly growing multi-layered colonies which rarely become confluent. A confluent monolayer is not formed.
Tissue Breast, mammary gland
Options selector
Catalog no. Size
300131 1 cryovial
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Field Specification
Mfr No 300131
Species Human
BT-474 is a human breast cancer cell line, derived from the ductal carcinoma of a 60-year-old female. This cell line is estrogen and progesterone receptor positive, making it a valuable model for studying hormone-responsive breast cancers. BT-474 cells are also characterized by the overexpression of HER2/neu (human epidermal growth factor receptor 2), a protein that is amplified and plays a critical role in the pathogenesis and progression of certain aggressive types of breast cancer. The BT-474 cell line is extensively used in oncological research to study the molecular mechanisms of breast cancer proliferation and to test therapeutic strategies targeting hormone receptors and the HER2 pathway. These cells are particularly useful for examining the efficacy of HER2-targeted therapies, such as trastuzumab (Herceptin), and for exploring mechanisms of resistance to these treatments. The cell line has also contributed to advancements in understanding how hormonal manipulations affect cancer cell growth and survival, providing insights into potential treatment approaches for hormone-dependent tumors.

SKU:BHC11100222

  • Receptors expressed: HER-2/NEU+, ER+, PR+
  • Isoenzymes: G6PD, B, PGM3, 1, PGM1, 1, ES-D, 1, Me-2, 0, AK-1, 1, GLO-1, 1, Phenotype Frequency Product: 0.0426
  • Tumorigenic: Yes, in nude mice
  • Virus susceptibility: mouse mammary tumor virus (RIII-MuMTV)
  • MSI status: Stable (MSS)
  • Mutational profile: TP53 mut
  • Karyotype: mode = 55, range = 50 to 112, bimodal shift 58 - 59 and 100 in later passages with 3 marker chromosomes
  • cultureMedium: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
  • supplements: Supplement the medium with 10% FBS, 10 microgram/mL Insulin
  • doublingTime: 60 to 80 hours
  • subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
  • seedingDensity: 2 x 104 cells/cm2 will yield in a mostly confluent layer in about 4 days
  • fluidRenewal: 2 to 3 times per week
  • postThawRecovery: Almost 100% recovered cells at >90% viability
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Matches this product
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today